Trade Summary
2 days ago, Brackmann Christoph, serving as CFO at Novocure Ltd (NVCR), sold 6,412 shares at $13.31 per share, for a total transaction value of $85,314.00. Following this transaction, Brackmann Christoph now holds 182,842 shares of NVCR.
This sale represents a 3.00% decrease in Brackmann Christoph's stake in the company. This is considered a medium-conviction trade.
The trade was executed on Wednesday, March 4, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, March 5, 2026, 1 day after the trade was made.
Novocure Ltd operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.